Rattel B - Search Results

1

[Realization of an online connection of laboratory apparatus with personal computers].

Schliack M, Rattel B. Schliack M, et al. Among authors: rattel b. Z Versuchstierkd. 1989;32(6):241-7. Z Versuchstierkd. 1989. PMID: 2694684 Review. German.

2

[ONLINE: program for online connection of laboratory apparatus with personal computers with special reference to the requirements of toxicological animal studies].

Rattel B, Schliack M. Rattel B, et al. Z Versuchstierkd. 1989;32(6):249-56. Z Versuchstierkd. 1989. PMID: 2618188 German.

3

The hypolipidemic effect of lifibrol during a long term treatment of pigs.

Schliack M, Löser R, Seibel K, Rattel B, Lang G. Schliack M, et al. Among authors: rattel b. Artery. 1990;18(1):1-15. Artery. 1990. PMID: 2085283

4

Preclinical data for Droloxifene.

Hasmann M, Rattel B, Löser R. Hasmann M, et al. Among authors: rattel b. Cancer Lett. 1994 Sep 15;84(2):101-16. doi: 10.1016/0304-3835(94)90364-6. Cancer Lett. 1994. PMID: 8076367 Review.

5

WK175, a novel antitumor agent, decreases the intracellular nicotinamide adenine dinucleotide concentration and induces the apoptotic cascade in human leukemia cells.

Wosikowski K, Mattern K, Schemainda I, Hasmann M, Rattel B, Löser R. Wosikowski K, et al. Among authors: rattel b. Cancer Res. 2002 Feb 15;62(4):1057-62. Cancer Res. 2002. PMID: 11861382

6

Antiangiogenic potency of FK866/K22.175, a new inhibitor of intracellular NAD biosynthesis, in murine renal cell carcinoma.

Drevs J, Löser R, Rattel B, Esser N. Drevs J, et al. Among authors: rattel b. Anticancer Res. 2003 Nov-Dec;23(6C):4853-8. Anticancer Res. 2003. PMID: 14981935

7

In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells.

Wosikowski K, Biedermann E, Rattel B, Breiter N, Jank P, Löser R, Jansen G, Peters GJ. Wosikowski K, et al. Among authors: rattel b. Clin Cancer Res. 2003 May;9(5):1917-26. Clin Cancer Res. 2003. PMID: 12738750

8

Preclinical Assessment of AMG 596, a Bispecific T-cell Engager (BiTE) Immunotherapy Targeting the Tumor-specific Antigen EGFRvIII.

Sternjak A, Lee F, Thomas O, Balazs M, Wahl J, Lorenczewski G, Ullrich I, Muenz M, Rattel B, Bailis JM, Friedrich M. Sternjak A, et al. Among authors: rattel b. Mol Cancer Ther. 2021 May;20(5):925-933. doi: 10.1158/1535-7163.MCT-20-0508. Epub 2021 Feb 25. Mol Cancer Ther. 2021. PMID: 33632870

9

Preclinical antitumor activity of the oral platinum analog satraplatin.

Wosikowski K, Lamphere L, Unteregger G, Jung V, Kaplan F, Xu JP, Rattel B, Caligiuri M. Wosikowski K, et al. Among authors: rattel b. Cancer Chemother Pharmacol. 2007 Sep;60(4):589-600. doi: 10.1007/s00280-007-0502-z. Epub 2007 May 31. Cancer Chemother Pharmacol. 2007. PMID: 17541592

10

The PSMA-targeting Half-life Extended BiTE Therapy AMG 160 has Potent Antitumor Activity in Preclinical Models of Metastatic Castration-resistant Prostate Cancer.

Deegen P, Thomas O, Nolan-Stevaux O, Li S, Wahl J, Bogner P, Aeffner F, Friedrich M, Liao MZ, Matthes K, Rau D, Rattel B, Raum T, Kufer P, Coxon A, Bailis JM. Deegen P, et al. Among authors: rattel b. Clin Cancer Res. 2021 May 15;27(10):2928-2937. doi: 10.1158/1078-0432.CCR-20-3725. Epub 2021 Jan 27. Clin Cancer Res. 2021. PMID: 33504551

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters